+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Polymerase Chain Reaction (PCR) Technologies and Global Markets 2021-2026

  • ID: 5412046
  • Report
  • August 2021
  • Region: Global
  • 136 Pages
  • BCC Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson And Co.
  • Biofire Diagnostics Llc
  • Bioneer Corp.
  • Bio-Rad Laboratories Inc.

The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.

The reagents and consumables market for PCR technology should grow from $6.3 billion in 2021 to $8.4 million by 2026, at a CAGR of 6.0% for the period of 2021-2026.

The software market for PCR technology should grow from $590.8 million in 2021 to $776.1 million by 2026, at a CAGR of 5.6% for the period of 2021-2026.

Report Scope

This report examines the market potential of PCR technology. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advances, drivers and restraints, and opportunity and trends in market growth. The report also covers market projections to 2026 and market rankings for key players. The report discusses the market share of PCR technologies based on type of product, technology and application.

This report segments the global market by four geographical regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW). For the purpose of this report, North America includes the U.S., Canada and Mexico; the European region includes Germany, U.K., France and Rest of Europe; the Asia-Pacific region includes China, India, Japan, and the Rest of Asia-Pacific; and RoW includes the Middle East, Africa and South America. For market estimates, data is provided for the year 2020 as the base year, 2019 as the historical year and forecasts are through year-end 2026.

Report Includes

  • 70 data tables and 15 additional tables
  • An updated review of the global market for polymerase chain reaction (PCR) technologies
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Discussion of major factors driving the growth of the PCR market, industry structure, regulatory scenario, and penetration of technologies in molecular diagnosis of infectious diseases
  • Estimation of market size and revenue sales forecast for PCR products, and corresponding market share analysis by product, technology type, application, and geographic region
  • Impact of the COVID-19 on the market for PCR technology, R&D efforts and the need to reinvent medical ventilators, current status and impact on Medtech
  • Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for PCR technology in clinical diagnostics
  • Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
  • Competitive landscape of the major players operating in the global market, their competitive environment and product portfolio analysis
  • Profile descriptions of the leading industry players including Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson And Co.
  • Biofire Diagnostics Llc
  • Bioneer Corp.
  • Bio-Rad Laboratories Inc.

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • What's New in this Update
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

  • Highlights of the PCR Market

Chapter 3 Background and Technology Overview

  • Evolution of PCR
  • Principles of PCR
  • Instruments and Components of PCR
  • Instruments
  • Target DNA
  • Primers
  • Enzyme and Enzyme Concentration
  • Buffers
  • Magnesium Concentration
  • Deoxyribonucleoside Triphosphates
  • Types of PCR
  • Reverse Transcription PCR
  • Nested PCR
  • Hot Start and Touchdown PCR
  • Inverse PCR
  • Multiplex PCR
  • Quantitative PCR
  • Traditional vs. Real-Time PCR
  • Design of Primer for PCR
  • Primer Selection
  • Primer Length
  • Melting Temperature
  • Specificity
  • G/C Content
  • 3' End Sequence
  • PCR Quantification Methods
  • Absolute Quantification
  • Relative Quantification
  • Components of Quantitative PCR
  • DNA Binding Dyes
  • Probes in qPCR
  • Controls for qPCR Experiments

Chapter 4 COVID-19 and R&D

  • Potential Targets for COVID-19 Drug Development
  • Basigin (CD147)
  • C-C Chemokine Receptor Type 5 (CCR5)
  • Envelope Protein (E) (SARS-CoV-2; COVID-19)
  • Epithelial Sodium Channel (ENaC)
  • Histamine N-Methyltransferase (HMT)
  • Interleukin-6 Receptor Subunit α (IL-6RA)
  • Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
  • Nucleocapsid (N) (SARS-CoV-2; COVID-19)
  • R&D on COVID-19
  • COVID-19 Clinical Trial Landscape

Chapter 5 Regulatory Structure of the COVID-19 Diagnostics Industry

  • Coronavirus Treatment Acceleration Program (CTAP)
  • Clinical Trials being Conducted during COVID-19 Pandemic
  • Response to Drug Shortages
  • National Regulatory Agencies for Ongoing Clinical Trials
  • U.S. FDA
  • Medicines and Healthcare Products Regulatory Agency (U.K.)
  • European Medicines Agency
  • COVID-19 Testing

Chapter 6 Polymerase Chain Reaction: Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities

Chapter 7 Impact of COVID-19 Pandemic

  • Outbreak
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Current Status and Impact on Medical Technology
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Delays of Clinical Trials
  • Supply Chain Disruptions
  • Medical Tourism

Chapter 8 Market Breakdown by Product Type

  • Global Market for PCR, by Product Type
  • Market Size and Forecast
  • PCR Instruments
  • Market Size and Forecast
  • Market Analysis
  • PCR Reagents and Consumables
  • Market Size and Forecast
  • Market Analysis
  • PCR Software
  • Market Size and Forecast
  • Market Analysis
  • PCR Services
  • Market Size and Forecast
  • Market Analysis

Chapter 9 Market Breakdown by Technology

  • Global Market for PCR, by Technology
  • Market Size and Forecast
  • Real-Time PCR
  • Market Size and Forecast
  • Market Analysis
  • Reverse Transcriptase PCR
  • Market Size and Forecast
  • Market Analysis
  • Inverse and Standard PCR
  • Market Size and Forecast
  • Market Analysis
  • Assembly and Nested PCR
  • Market Size and Forecast
  • Market Analysis
  • Hot Start and Touchdown PCR
  • Market Size and Forecast
  • Market Analysis
  • Multiplex PCR and Other PCR
  • Market Size and Forecast
  • Market Analysis

Chapter 10 Market Breakdown by Application

  • Global Market for PCR Technology, by Application
  • Research Applications
  • Market Size and Forecast
  • Market Analysis
  • Clinical Applications
  • Market Size and Forecast
  • Market Analysis
  • Other PCR Applications
  • Market Size and Forecast
  • Market Analysis

Chapter 11 Market Breakdown by Region

  • Global Market for PCR Technology, by Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 12 Competitive Landscape

  • Global Company Shares

Chapter 13 Company Profiles

  • Abbott Laboratories
  • Becton, Dickinson And Co.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen Nv
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Biofire Diagnostics Llc
  • Bioneer Corp.
  • Eppendorf Ag

Chapter 14 Appendix: List of Abbreviations

List of Tables
Summary Table A: Global Market for PCR Technology, by Product Type, Through 2026
Summary Table B: Global Market for PCR Technology, by Technology, Through 2026
Summary Table C: Global Market for PCR Technology, by Application, Through 2026
Table 1: Traditional vs. Real-Time PCR
Table 2: Advantages and Disadvantages of Dye-Based Detection
Table 3: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
Table 4: COVID-19 Therapeutics in Development, by Biopharmaceutical Company Collaboration
Table 5: COVID-19 Vaccines in Development, by Biopharmaceutical Companies Collaboration
Table 6: COVID-19 Vaccines in Development, by Biopharmaceutical Company Collaboration
Table 7: Number of Clinical Trials on COVID-19, by Country
Table 8: Distribution of COVID-19 Clinical Symptoms
Table 9: Number of COVID-19 Confirmed Cases and Deaths, by Region, July 21, 2021
Table 10: Distribution of COVID-19 Clinical Symptoms
Table 11: Global Market for PCR Technology, by Product, Through 2026
Table 12: Global Market for PCR Instruments, by Type, Through 2026
Table 13: Global Market for PCR Instruments, by Region, Through 2026
Table 14: North American Market for PCR Instruments, by Country, Through 2026
Table 15: European Market for PCR Instruments, by Country, Through 2026
Table 16: Asia-Pacific Market for PCR Instruments, by Country, Through 2026
Table 17: Global Market for PCR Reagents and Consumables, by Type, Through 2026
Table 18: Global Market for PCR Reagents and Consumables, by Region, Through 2026
Table 19: North American Market for PCR Reagents and Consumables, by Country, Through 2026
Table 20: European Market for PCR Reagents and Consumables, by Country, Through 2026
Table 21: Asia-Pacific Market for PCR Reagents and Consumables, by Country, Through 2026
Table 22: Global Market for PCR Software, by Type, Through 2026
Table 23: Global Market for PCR Software, by Region, Through 2026
Table 24: North American Market for PCR Software, by Country, Through 2026
Table 25: European Market for PCR Software, by Country, Through 2026
Table 26: Asia-Pacific Market for PCR Software, by Country, Through 2026
Table 27: Global Market for PCR Services, by Region, Through 2026
Table 28: North American Market for PCR Services, by Country, Through 2026
Table 29: European Market for PCR Services, by Country, Through 2026
Table 30: Asia-Pacific Market for PCR Services, by Country, Through 2026
Table 31: Global Market for Real-time PCR, by Region, Through 2026
Table 32: North American Market for Real-time PCR, by Country, Through 2026
Table 33: European Market for Real-time PCR, by Country, Through 2026
Table 34: Asia-Pacific Market for Real-time PCR, by Country, Through 2026
Table 35: Global Market for Reverse Transcriptase PCR, by Region, Through 2026
Table 36: North American Market for Reverse Transcriptase PCR, by Country, Through 2026
Table 37: European Market for Reverse Transcriptase PCR, by Country, Through 2026
Table 38: Asia-Pacific Market for Reverse Transcriptase PCR, by Country, Through 2026
Table 39: Global Market for Inverse and Standard PCR, by Region, Through 2026
Table 40: North American Market for Inverse and Standard PCR, by Country, Through 2026
Table 41: European Market for Inverse and Standard PCR, by Country, Through 2026
Table 42: Asia-Pacific Market for Inverse and Standard PCR, by Country, Through 2026
Table 43: Global Market for Assembly and Nested PCR, by Region, Through 2026
Table 44: North American Market for Assembly and Nested PCR, by Country, Through 2026
Table 45: European Market for Assembly and Nested PCR, by Country, Through 2026
Table 46: Asia-Pacific Market for Assembly and Nested PCR, by Country, Through 2026
Table 47: Global Market for Hot Start and Touchdown PCR, by Region, Through 2026
Table 48: North American Market for Hot Start and Touchdown PCR, by Country, Through 2026
Table 49: European Market for Hot Start and Touchdown PCR, by Country, Through 2026
Table 50: Asia-Pacific Market for Hot Start and Touchdown PCR, by Country, Through 2026
Table 51: Global Market for Multiplex and Other PCR, by Region, Through 2026
Table 52: North American Market for Multiplex and Other PCR, by Country, Through 2026
Table 53: European Market for Multiplex and Other PCR, by Country, Through 2026
Table 54: Asia-Pacific Market for Multiplex and Other PCR, by Country, Through 2026
Table 55: Global Market for PCR Technology, by Application, Through 2026
Table 56: Global Market for Research Applications, by Region, Through 2026
Table 57: North American Market for Research Applications, by Country, Through 2026
Table 58: European Market for Research Applications, by Country, Through 2026
Table 59: Asia-Pacific Market for Research Applications, by Country, Through 2026
Table 60: Global Market for Clinical Applications, by Region, Through 2026
Table 61: North American Market for Clinical Applications, by Country, Through 2026
Table 62: European Market for Clinical Applications, by Country, Through 2026
Table 63: Asia-Pacific Market for Clinical Applications, by Country, Through 2026
Table 64: Global Market for Other PCR Applications, by Region, Through 2026
Table 65: North American Market for Other PCR Applications, by Country, Through 2026
Table 66: European Market for Other PCR Applications, by Country, Through 2026
Table 67: Asia-Pacific Market for Other PCR Applications, by Country, Through 2026
Table 68: Global Market for PCR Technology, by Region, Through 2026
Table 69: North American Market for PCR Technology, by Country, Through 2026
Table 70: European Market for PCR Technology, by Country, Through 2026
Table 71: Asia-Pacific Market for PCR Technology, by Country, Through 2026
Table 72: Global Market Shares of PCR Instruments, by Company, 2020
Table 73: Global Market Shares of PCR Reagents and Consumables, by Company, 2020
Table 74: Global Market Shares of PCR Software, by Company, 2020
Table 75: Abbott: Financials, 2016-2020
Table 76: Abbott: Product Portfolio, by Business Segment
Table 77: Becton, Dickinson and Co.: Product Portfolio
Table 78: Bio-Rad Laboratories: PCR Tools
Table 79: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 80: F. Hoffmann-La Roche Ltd.: Recent Developments, 2020 and 2021
Table 81: Qiagen NV: Financials, 2018-2020
Table 82: Qiagen NV: Products and Services
Table 83: Thermo Fisher Scientific: Product Portfolio
Table 84: Abbreviations Used in the PCR Technology Industry

List of Figures
Summary Figure A: Global Market for PCR Technology, by Product Type, 2019-2026
Summary Figure B: Global Market for PCR Technology, by Technology, 2019-2026
Summary Figure C: Global Market for PCR Technology, by Application, 2019-2026
Figure 1: Global Market Shares of PCR Technology, by Product, 2020
Figure 2: Global Market for PCR Instruments, 2019-2026
Figure 3: Global Market for PCR Reagents and Consumables, 2019-2026
Figure 4: Global Market for PCR Software, 2019-2026
Figure 5: Global Market for PCR Services, 2019-2026
Figure 6: Global Market Shares of PCR, by Technology, 2020
Figure 7: Global Market Shares of PCR Technology, by Application, 2020
Figure 8: Global Market Shares of PCR Technology, by Region, 2019
Figure 9: North American Market Shares of PCR Technology, by Country, 2020
Figure 10: Number of COVID-19 Cases, by U.S. State
Figure 11: European Market Shares of PCR Technology, by Country, 2020
Figure 12: Asia-Pacific Market Shares of PCR Technology, by Country, 2020
Figure 13: Abbott: Revenue Share, by Country, 2020
Figure 14: Abbott: Revenue Share, by Business Segments, 2020
Figure 15: Becton, Dickinson and Co.: Annual Revenue, 2019 and 2020
Figure 16: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2020
Figure 17: Bio-Rad Laboratories: Annual Revenue, 2019 and 2020
Figure 18: Bio-Rad Laboratories: Revenue Share, by Business Segment, 2020
Figure 19: Bio-Rad Laboratories: Revenue Share, by Region, 2020
Figure 20: F. Hoffmann-La Roche Ltd.: Annual Revenue, 2018-2020
Figure 21: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2020
Figure 22: Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 23: Thermo Fisher Scientific: Revenue Share, by Product Category, 2020

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson And Co.
  • Biofire Diagnostics Llc
  • Bioneer Corp.
  • Bio-Rad Laboratories Inc.

The molecular diagnostic industry is an integral part of the healthcare industry. It is continuously evolving with the advent of novel technologies such as polymerase chain reaction (PCR), deoxyribonucleic acid (DNA) sequencing and next-generation sequencing (NGS). PCR technology has vast potential in the fields of proteomics and genomics and has revolutionized the molecular and functional genomics sector. PCR technology includes real-time PCR, reverse transcriptase PCR, hot start and touchdown PCR, and multiplex PCR.

Technology drivers of the PCR market include advances in instrumentation, reagents and PCR techniques, and increasing R&D. Health- and healthcare-related drivers include increasingly sedentary lifestyles, the growing incidence of diseases such as diabetes, cancer and cardiovascular, and the increasing percentage of baby-boomers. The use of PCR is increasing beyond the conventional markets. Research labs and institutions are using PCR for various research activities for pharmaceutical companies, biotech and drug/product discovery companies, forensic labs and clinical diagnostic labs.

Reagents and consumables is the largest market segment in terms of revenues. The availability of ready-made mixes and reagents has spurred the growth of the reagent market. The instruments segment, which includes real-time PCR instruments and thermal cycles, is another high-growth area. Real-time PCR technology has opened up the arena of PCR applications ranging from the diagnosis of infectious diseases to DNA fingerprinting in forensic science. The number of companies entering the PCR reagent business is on the rise, with most of these new entrants being small local companies, but to meet the market demand for new products and reagents, many of these companies must enter into partnerships or collaborations with leading and larger market players, especially for product development and distribution.

Leading companies in this market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Promega Corp. and Merck KGaA (Sigma-Aldrich).

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson And Co.
  • Bio-Rad Laboratories Inc.
  • Biofire Diagnostics Llc
  • Bioneer Corp.
  • Eppendorf Ag
  • F. Hoffmann-La Roche Ltd.
  • Qiagen Nv
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll